Tags

Type your tag names separated by a space and hit enter

International travel patterns and travel risks of patients diagnosed with cancer.
J Travel Med. 2013 Mar-Apr; 20(2):71-7.JT

Abstract

BACKGROUND

Immunocompromised travelers living with cancer can be at increased risk of travel-related illnesses. Their international travel patterns and associated risks remain largely unknown.

METHODS

This was a retrospective cohort study of all patients diagnosed with cancer who presented for pre-travel health advice between January 1, 2003 and June 30, 2011. Demographics, travel patterns, and infectious diseases exposure risks of immunocompromised travelers were characterized and compared with those of immunocompetent travelers. Reported travel-related illnesses were assessed in both groups.

RESULTS

A total of 149 travelers were included in this study. Fifty-one percent had solid tumors, 32% had hematological malignancies, and 17% underwent stem cell transplantation. Seventy travelers (47%) were immunocompromised. Immunocompromised travelers had similar demographics, trip itineraries, and infectious diseases exposure risks to hepatitis A, malaria, typhoid fever, and yellow fever as immunocompetent travelers. Most of the reported travel-related illnesses were of minor nature.

CONCLUSION

Travelers with cancer who have impaired immunity had similar infectious diseases exposure risks and travel patterns as travelers whose cancer is cured or in remission. Improved understanding of travel patterns and risks of patients with cancer may assist in providing more focused pre-travel health interventions to this complex subset of travelers.

Links

Aggregator Full Text
Publisher Full Text
academic.oup.com
onlinelibrary.wiley.com

Authors+Show Affiliations

Mikati T
Infectious Disease Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College, New York, NY 10065, USA.
Taur Y
No affiliation info available
Seo SK
No affiliation info available
Shah MK
No affiliation info available

MeSH

AdultAgedCell TransplantationCommunicable Disease ControlCommunicable DiseasesDemographyDeveloping CountriesFemaleHealth Knowledge, Attitudes, PracticeHumansImmunocompromised HostMaleMiddle AgedNeoplasmsPreventive Health ServicesRetrospective StudiesRisk AssessmentTravelTravel Medicine

Pub Type(s)

Comparative Study
Journal Article

Language

eng

PubMed ID

23464712

Citation

Mikati, Tarek, et al. "International Travel Patterns and Travel Risks of Patients Diagnosed With Cancer." Journal of Travel Medicine, vol. 20, no. 2, 2013, pp. 71-7.
Mikati T, Taur Y, Seo SK, et al. International travel patterns and travel risks of patients diagnosed with cancer. J Travel Med. 2013;20(2):71-7.
Mikati, T., Taur, Y., Seo, S. K., & Shah, M. K. (2013). International travel patterns and travel risks of patients diagnosed with cancer. Journal of Travel Medicine, 20(2), 71-7. https://doi.org/10.1111/jtm.12013
Mikati T, et al. International Travel Patterns and Travel Risks of Patients Diagnosed With Cancer. J Travel Med. 2013 Mar-Apr;20(2):71-7. PubMed PMID: 23464712.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - International travel patterns and travel risks of patients diagnosed with cancer. AU - Mikati,Tarek, AU - Taur,Ying, AU - Seo,Susan K, AU - Shah,Monika K, Y1 - 2013/01/30/ PY - 2013/3/8/entrez PY - 2013/3/8/pubmed PY - 2013/8/29/medline SP - 71 EP - 7 JF - Journal of travel medicine JO - J Travel Med VL - 20 IS - 2 N2 - BACKGROUND: Immunocompromised travelers living with cancer can be at increased risk of travel-related illnesses. Their international travel patterns and associated risks remain largely unknown. METHODS: This was a retrospective cohort study of all patients diagnosed with cancer who presented for pre-travel health advice between January 1, 2003 and June 30, 2011. Demographics, travel patterns, and infectious diseases exposure risks of immunocompromised travelers were characterized and compared with those of immunocompetent travelers. Reported travel-related illnesses were assessed in both groups. RESULTS: A total of 149 travelers were included in this study. Fifty-one percent had solid tumors, 32% had hematological malignancies, and 17% underwent stem cell transplantation. Seventy travelers (47%) were immunocompromised. Immunocompromised travelers had similar demographics, trip itineraries, and infectious diseases exposure risks to hepatitis A, malaria, typhoid fever, and yellow fever as immunocompetent travelers. Most of the reported travel-related illnesses were of minor nature. CONCLUSION: Travelers with cancer who have impaired immunity had similar infectious diseases exposure risks and travel patterns as travelers whose cancer is cured or in remission. Improved understanding of travel patterns and risks of patients with cancer may assist in providing more focused pre-travel health interventions to this complex subset of travelers. SN - 1708-8305 UR - https://www.unboundmedicine.com/medline/citation/23464712/International_travel_patterns_and_travel_risks_of_patients_diagnosed_with_cancer_ L2 - https://academic.oup.com/jtm/article-lookup/doi/10.1111/jtm.12013 DB - PRIME DP - Unbound Medicine ER -